secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K/A
Filed at:   2022-09-30T23:59:59+00:00
Accession:  0001104659-22-104578
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech grants new CFO Gemma Brown options to acquire 334,000 shares
----------------------------------------------------------------------

- Options granted on Sep 26, 2022 under the 2021 Share Award Plan.
- Options vest in three equal annual installments subject to continued employment.
- On death or non-misconduct termination, unvested options may vest per Board; forfeiture on misconduct.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922104578/0001104659-22-104578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922104578/tm2227040d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-104578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer